Park Avenue Securities LLC raised its stake in CME Group Inc. (NASDAQ:CME) by 14.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,047 shares of the financial services provider’s stock after buying an additional 262 shares during the period. Park Avenue Securities LLC’s holdings in CME Group were worth $259,000 at the end of the most recent quarter.
A number of other large investors have also bought and sold shares of the company. Huntington National Bank raised its position in CME Group by 4.7% in the first quarter. Huntington National Bank now owns 851 shares of the financial services provider’s stock valued at $100,000 after buying an additional 38 shares during the last quarter. Coconut Grove Bank raised its position in CME Group by 95.7% in the first quarter. Coconut Grove Bank now owns 900 shares of the financial services provider’s stock valued at $107,000 after buying an additional 440 shares during the last quarter. Whittier Trust Co. raised its position in CME Group by 12.6% in the first quarter. Whittier Trust Co. now owns 1,030 shares of the financial services provider’s stock valued at $122,000 after buying an additional 115 shares during the last quarter. Parallel Advisors LLC raised its position in CME Group by 4.1% in the first quarter. Parallel Advisors LLC now owns 1,084 shares of the financial services provider’s stock valued at $128,000 after buying an additional 43 shares during the last quarter. Finally, RidgeWorth Capital Management LLC raised its position in CME Group by 55.5% in the first quarter. RidgeWorth Capital Management LLC now owns 1,138 shares of the financial services provider’s stock valued at $135,000 after buying an additional 406 shares during the last quarter. Institutional investors and hedge funds own 83.25% of the company’s stock.
CME Group Inc. (NASDAQ CME) opened at 125.39 on Friday. The stock has a market capitalization of $42.62 billion, a P/E ratio of 25.60 and a beta of 0.73. The firm’s 50-day moving average is $123.50 and its 200-day moving average is $121.16. CME Group Inc. has a 12-month low of $98.95 and a 12-month high of $127.96.
CME Group (NASDAQ:CME) last issued its earnings results on Tuesday, August 1st. The financial services provider reported $1.23 EPS for the quarter, topping analysts’ consensus estimates of $1.20 by $0.03. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The firm had revenue of $925 million for the quarter, compared to the consensus estimate of $931.05 million. During the same quarter in the prior year, the business earned $1.14 earnings per share. The company’s revenue was up 2.1% compared to the same quarter last year. Analysts predict that CME Group Inc. will post $4.80 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Monday, September 25th. Stockholders of record on Friday, September 8th will be paid a $0.66 dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 2.11%. CME Group’s payout ratio is 53.99%.
CME has been the subject of several analyst reports. Jefferies Group LLC restated a “buy” rating and set a $128.00 price target on shares of CME Group in a report on Monday, July 10th. Deutsche Bank AG reiterated a “buy” rating and issued a $133.00 price objective (down previously from $134.00) on shares of CME Group in a research note on Monday, May 15th. Keefe, Bruyette & Woods reiterated a “hold” rating and issued a $127.00 price objective on shares of CME Group in a research note on Friday, July 14th. Citigroup Inc. initiated coverage on shares of CME Group in a research note on Wednesday, July 12th. They issued a “buy” rating and a $140.00 price objective for the company. Finally, BidaskClub upgraded shares of CME Group from a “sell” rating to a “hold” rating in a research note on Friday, June 23rd. One investment analyst has rated the stock with a sell rating, two have given a hold rating and six have assigned a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $131.63.
In other CME Group news, insider Sunil Cutinho sold 10,265 shares of the stock in a transaction that occurred on Wednesday, May 24th. The stock was sold at an average price of $117.85, for a total transaction of $1,209,730.25. Following the transaction, the insider now owns 21,690 shares in the company, valued at $2,556,166.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Martin J. Gepsman sold 200 shares of the stock in a transaction that occurred on Wednesday, August 9th. The stock was sold at an average price of $126.14, for a total value of $25,228.00. Following the transaction, the director now owns 43,311 shares in the company, valued at approximately $5,463,249.54. The disclosure for this sale can be found here. Insiders sold 91,085 shares of company stock worth $11,242,896 in the last 90 days. Company insiders own 0.61% of the company’s stock.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.